1134635-03-2

Basic information

• Product Name: GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP
• Synonyms: GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP;(1-3)Galα(1-4)GalβGalNAcβ(1-3)Galα(1-4)Galβ(1-4)Glc-β4-Nitrophenyl b-globo-N-tetraoside
• CAS NO: 1134635-03-2
• Molecular Formula: C32H48N2O23
• Molecular Weight: 828.72312
• Mol File: 1134635-03-2.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: <0°C
• CAS DataBase Reference: GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP(CAS DataBase Reference)
• NIST Chemistry Reference: GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP(1134635-03-2)
• EPA Substance Registry System: GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP(1134635-03-2)

Safety Data

• Hazardous Substances Data: 1134635-03-2(Hazardous Substances Data)

Usage

Description

GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP is a glycoprotein that contains a specific type of sugar molecule known as a glycosaminoglycan (GAG). GAGs are important components of the extracellular matrix and are involved in various biological functions, including cell signaling, cell adhesion, and tissue development. This particular chemical structure consists of a series of sugars connected by specific bonds, and it also contains a p-nitrophenol (pNP) group. The presence of these specific sugars and the pNP group gives this molecule its unique properties and potential functions in biological processes.

Uses

Used in Research Applications:
GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP is used as a research tool for studying the role of glycosaminoglycans (GAGs) in various biological processes. The presence of specific sugars and the pNP group allows researchers to investigate the interactions between GAGs and other molecules, as well as their potential functions in cell signaling, cell adhesion, and tissue development.
Used in Pharmaceutical Industry:
GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP is used as a potential therapeutic agent for diseases involving glycan structures, such as cancer. Studies on this chemical may provide insights into its role in these diseases and help in the development of targeted therapies.
Used in Diagnostic Applications:
GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP can be used as a diagnostic marker for conditions involving glycan structures. The presence of the pNP group allows for the detection and quantification of this molecule in biological samples, which can help in the diagnosis and monitoring of diseases related to GAGs.